Probiotics show potential benefits for gut microbiota stability, mental wellbeing, immune function, and some gastrointestinal symptoms, but effects vary by strain and condition. Evidence is generally positive but limited by study size and heterogeneity.
Multiple high-quality randomized controlled trials indicate that specific probiotic strains such as Lactobacillus, Lactiplantibacillus plantarum, and Bifidobacterium breve can support gut microbiota stability, improve mental wellbeing, enhance immune function, and modestly affect gastrointestinal symptoms in healthy adults and older women. For example, Lactiplantibacillus plantarum Probio87 improved mood, anxiety, sleep, and immune gene expression in healthy women. Bifidobacterium breve 207-1 influenced neurotransmitters and improved sleep quality and lifestyle behaviors in healthy adults. Lactobacillus strains showed minor microbiota changes and some stress reduction but no consistent digestive health improvements in older adults. Probiotics may also reduce symptoms in hepatic encephalopathy, though evidence quality is low. Some studies found no significant effects on primary outcomes or mixed results influenced by lifestyle factors. Safety profiles were generally good with minimal adverse effects reported. Limitations include small sample sizes, short durations, strain heterogeneity, and some studies with high risk of bias.
Effects appeared after 6 weeks; benefits linked to immune and gut-brain axis modulation.
No significant mood score changes; mechanism may involve short-chain fatty acids.
No major changes in wellness indicators; strain recovery confirmed.
Probiotics were generally well tolerated with minimal adverse effects reported across studies. Some prebiotic mixtures caused mild gastrointestinal symptoms such as belching and urgency. No serious safety concerns or probiotic-related infections were reported.
Many studies had small sample sizes and short durations. Strain-specific effects limit generalizability. Some trials had high risk of bias or unclear funding sources. Evidence for some conditions like hepatic encephalopathy is low quality. Effects may be influenced by lifestyle factors and individual variability. Mood and mental health benefits require further confirmation.